Dyslipidemia: Definition and Pathophysiology
5 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is dyslipidemia defined as?

elevated total cholesterol, elevated low-density lipoprotein (LDL) cholesterol, elevated triglycerides, low high-density lipoprotein (HDL) cholesterol, or a combination of these abnormalities

Which lipoprotein classification is associated with 'Isolated hypercholesterolemia'?

  • III (intermediate-density lipoprotein 'IDL')
  • I (chylomicrons)
  • IIb (LDL + VLDL)
  • IIa (LDL) (correct)
  • Most patients with dyslipidemia are ________ for many years.

    asymptomatic

    Familial hypercholesterolemia is characterized by a selective elevation in plasma LDL.

    <p>True</p> Signup and view all the answers

    Match the following lipoprotein disorders with their descriptions:

    <p>I (chylomicrons) = Chylomicrons classification IIa (LDL) = Isolated hypercholesterolemia IIb (LDL + VLDL) = Combined hyperlipidemia III (intermediate-density lipoprotein 'IDL') = Intermediate-density lipoprotein classification IV (VLDL) = Familial hypertriglyceridemia V (VLDL + chylomicrons) = Chylomicrons and VLDL classification</p> Signup and view all the answers

    Study Notes

    Definition

    • Dyslipidemia is defined as abnormal levels of lipids in the blood
    • Elevated total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides
    • Low levels of high-density lipoprotein (HDL) cholesterol

    Pathophysiology

    • Cholesterol, triglycerides, and phospholipids are transported in blood as lipoprotein complexes
    • Elevated total and LDL cholesterol, and reduced HDL cholesterol, are associated with coronary heart disease (CHD)
    • Risk factors, such as oxidized LDL, mechanical injury to the endothelium, and excessive homocysteine, lead to endothelial dysfunction and atherosclerosis
    • Eventual clinical outcomes may include angina, myocardial infarction, arrhythmias, stroke, peripheral arterial disease, abdominal aortic aneurysm, and sudden death

    Types of Dyslipidemia

    • Primary or genetic lipoprotein disorders are classified into six categories:
      • I (chylomicrons)
      • IIa (LDL) - "Isolated hypercholesterolemia" or "Familial hypercholesterolemia"
      • IIb (LDL + VLDL) - "Combined hyperlipidemia"
      • III (intermediate-density lipoprotein - IDL)
      • IV (VLDL) - "Familial hypertriglyceridemia"
      • V (VLDL + chylomicrons)
    • Secondary forms of hyperlipidemia may be caused by certain drug classes, such as progestins, thiazide diuretics, glucocorticoids, β-blockers, isotretinoin, protease inhibitors, cyclosporine, mirtazapine, and sirolimus

    Clinical Presentation

    • Most patients are asymptomatic for many years
    • Symptomatic patients may complain of chest pain, palpitations, sweating, anxiety, shortness of breath, abdominal pain, or loss of consciousness or difficulty with speech or movement
    • Familial hypercholesterolemia is characterized by a selective elevation in plasma LDL and deposition of LDL-derived cholesterol in tendons (xanthomas) and arteries (atheromas)

    Diagnosis

    • A fasting (12 hours or longer) lipoprotein profile, including total cholesterol, LDL, HDL, and triglycerides, should be measured in all adults 20 years or older at least once every 5 years
    • A complete history and physical examination should assess cardiovascular risk factors, family history, and secondary causes of dyslipidemia
    • Diabetes mellitus and the metabolic syndrome are considered CHD risk equivalents
    • Metabolic syndrome is characterized by abdominal obesity, atherogenic dyslipidemia, increased blood pressure, insulin resistance, and prothrombotic and proinflammatory states

    Treatment

    • The goals of treatment are to lower total and LDL cholesterol and reduce the risk of first or recurrent events, such as myocardial infarction, angina, heart failure, ischemic stroke, and peripheral arterial disease
    • The National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) recommends a fasting lipoprotein profile and risk factor assessment for initial classification of adults
    • Major risk factors include age, family history of premature CHD, cigarette smoking, hypertension, and low HDL cholesterol

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Learn about dyslipidemia, a condition characterized by abnormal levels of cholesterol and lipids in the blood. Understand the definition, pathophysiology, and effects of elevated cholesterol, LDL, and triglycerides, and low HDL cholesterol.

    More Like This

    Dyslipidemia Therapeutics II
    10 questions

    Dyslipidemia Therapeutics II

    ConscientiousCoconutTree avatar
    ConscientiousCoconutTree
    Dyslipidemia: Abnormal Lipid Metabolism
    6 questions
    Dyslipidemia: Lipid Metabolism Abnormality
    6 questions
    Use Quizgecko on...
    Browser
    Browser